LESLIE LARTEY: Open Payments
NPI 1447891569 · CULPEPER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 17 payments from 9 companies in 2025. Trend: 2023 $32 · 2024 $239 · 2025 $420
Food & beverage: $360Education: $60
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 2 | $93 |
| Travere Therapeutics, Inc. | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Calliditas Therapeutics US Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| ABBVIE INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Novo Nordisk Inc | 1 | $29 |
| Ardelyx, Inc. | 1 | $23 |
Products named: ACTHAR, JYNARQUE, TARPEYO, SPRAVATO, VRAYLAR, FARXIGA, Wegovy, IBSRELA.
Industry payments across VA — which companies pay providers there.
